+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity

  • ID: 5057745
  • Report
  • May 2020
  • Region: Global
  • 178 pages
  • GMD Research
1 of 4

Order now to receive an updated version of this report covering the impact of COVID-19.

Enquire Now

FEATURED COMPANIES

  • Atomwise, Inc.
  • Bioage
  • Deep Genomics
  • Google
  • Microsoft Corporation
  • NVIDIA Corporation
  • MORE
Global artificial intelligence (AI) in drug discovery market will reach $2.57 billion by 2026, growing by 30.3% annually over 2020-2026 despite the COVID-19 impact.

Highlighted with 86 tables and 86 figures, this 178-page report “Global Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Region.

Based on offering, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Software
  • Service
Based on technology, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Technologies
Based on drug type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Large-molecule Drugs
  • Small-molecular Drugs
Based on therapeutic area, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Other Therapeutic Areas
Based on application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Information & Data Analysis
  • Drug Design
  • Drug Evaluation
  • Clinical Trials
  • Other Applications
Based on end user, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
Geographically, the following regions together with the listed national/local markets are fully investigated:
  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • RoW (Saudi Arabia, UAE, Egypt)
For each of the aforementioned regions and countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global AI in drug discovery market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
  • Atomwise, Inc.
  • BenevolentAI
  • Berg LLC
  • Bioage
  • BIOAGE
  • Cloud Pharmaceuticals, Inc.
  • Cyclica
  • Deep Genomics
  • Envisagenics
  • Exscientia
  • Google
  • IBM Corporation
  • Insilico Medicine
  • Microsoft Corporation
  • Numedii, Inc.
  • Numerate
  • NVIDIA Corporation
  • Owkin, Inc.
  • Twoxar, Incorporated
  • Verge Genomics
  • Xtalpi, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Atomwise, Inc.
  • Bioage
  • Deep Genomics
  • Google
  • Microsoft Corporation
  • NVIDIA Corporation
  • MORE
1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Offering
3.1 Market Overview by Offering
3.2 Software
3.3 Service

4 Segmentation of Global Market by Technology
4.1 Market Overview by Technology
4.2 Deep Learning
4.3 Supervised Learning
4.4 Reinforcement Learning
4.5 Unsupervised Learning
4.6 Other Technologies

5 Segmentation of Global Market by Drug Type
5.1 Market Overview by Drug Type
5.2 Large-molecule Drugs
5.3 Small-molecular Drugs

6 Segmentation of Global Market by Therapeutic Area
6.1 Market Overview by Therapeutic Area
6.2 Oncology
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Disease
6.5 Metabolic Diseases
6.6 Other Therapeutic Areas

7 Segmentation of Global Market by Application
7.1 Market Overview by Application
7.2 Information & Data Analysis
7.3 Drug Design
7.4 Drug Evaluation
7.5 Clinical Trials
7.6 Other Applications

8 Segmentation of Global Market by End User
8.1 Market Overview by End User
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Contract Research Organizations

9 Segmentation of Global Market by Region
9.1 Geographic Market Overview 2019-2026
9.2 North America Market 2019-2026 by Country
9.2.1 Overview of North America Market
9.2.2 U.S.
9.2.3 Canada
9.2.4 Mexico
9.3 European Market 2019-2026 by Country
9.3.1 Overview of European Market
9.3.2 UK
9.3.3 France
9.3.4 Germany
9.3.5 Spain
9.3.6 Italy
9.3.7 Russia
9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2019-2026 by Country
9.4.1 Overview of Asia-Pacific Market
9.4.2 China
9.4.3 Japan
9.4.4 India
9.4.5 Australia
9.4.6 South Korea
9.4.7 Rest of APAC Region
9.5 South America Market 2019-2026 by Country
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America Market
9.6 Rest of World Market 2019-2026 by Country
9.6.1 UAE
9.6.2 Saudi Arabia
9.6.3 Egypt
9.6.4 Other National Markets

10 Competitive Landscape
10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
  • Atomwise, Inc.
  • BenevolentAI
  • Berg LLC
  • Bioage
  • BIOAGE
  • Cloud Pharmaceuticals, Inc.
  • Cyclica
  • Deep Genomics
  • Envisagenics
  • Exscientia
  • Google
  • IBM Corporation
  • Insilico Medicine
  • Microsoft Corporation
  • Numedii, Inc.
  • Numerate
  • NVIDIA Corporation
  • Owkin, Inc.
  • Twoxar, Incorporated
  • Verge Genomics
  • Xtalpi, Inc.
11 Investing in Global Market: Risk Assessment and Management
11.1 Risk Evaluation of Global Market
11.2 Critical Success Factors (CSFs)

List of Tables
Table 1. Snapshot of Global AI in Drug Discovery Market, 2019-2026
Table 2. Main Product Trends and Market Opportunities in Global AI in Drug Discovery Market
Table 3. Global AI in Drug Discovery Market by Offering, 2015-2026, $ mn
Table 4. Global AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 5. Global AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn
Table 6. Global AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 7. Selected Drug Development Pipelines Aided by AI
Table 8. Global AI in Drug Discovery Market by Application, 2015-2026, $ mn
Table 9. Global AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 10. Global AI in Drug Discovery Market by Region, 2015-2026, $ mn
Table 11. Leading National AI in Drug Discovery Market, 2019 and 2026, $ mn
Table 12. North America AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 13. U.S. AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 14. U.S. AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 15. U.S. AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 16. Canada AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 17. Canada AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 18. Canada AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 19. Mexico AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 20. Mexico AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 21. Mexico AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 22. Europe AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 23. UK AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 24. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 25. UK AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 26. France AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 27. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 28. France AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 29. Germany AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 30. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 31. Germany AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 32. Spain AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 33. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 34. Spain AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 35. Italy AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 36. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 37. Italy AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 38. Russia AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 39. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 40. Russia AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 41. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, $ mn
Table 42. APAC AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 43. China AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 44. China AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 45. China AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 46. Japan AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 47. Japan AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 48. Japan AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 49. India AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 50. India AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 51. India AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 52. Australia AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 53. Australia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 54. Australia AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 55. South Korea AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 56. South Korea AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 57. South Korea AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 58. AI in Drug Discovery Market in Rest of APAC by Country, 2015-2026, $ mn
Table 59. South America AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 60. Argentina AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 61. Argentina AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 62. Argentina AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 63. Brazil AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 64. Brazil AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 65. Brazil AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 66. Chile AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 67. Chile AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 68. Chile AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 69. RoW AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 70. UAE AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 71. UAE AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 72. UAE AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 73. Saudi Arabia AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 74. Saudi Arabia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 75. Saudi Arabia AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 76. Egypt AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 77. Egypt AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 78. Egypt AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 79. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies
Table 80. Atomwise, Inc.: Company Snapshot
Table 81. Atomwise, Inc.: Business Segmentation
Table 82. Atomwise, Inc.: Product Portfolio
Table 83. Atomwise, Inc.: Revenue, 2016-2018, $ mn
Table 84. Atomwise, Inc.: Recent Developments
Table 85. Risk Evaluation for Investing in Global Market, 2019-2026
Table 86. Critical Success Factors and Key Takeaways

List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 5. Global AI in Drug Discovery Market, 2019-2026, $ mn
Figure 6. Primary Drivers and Impact Factors of Global AI in Drug Discovery Market
Figure 7. Primary Restraints and Impact Factors of Global AI in Drug Discovery Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Global AI in Drug Discovery Market
Figure 10. Breakdown of Global AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue
Figure 11. Contribution to Global 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%)
Figure 12. Global AI in Drug Discovery Market: Software, 2015-2026, $ mn
Figure 13. Global AI in Drug Discovery Market: Service, 2015-2026, $ mn
Figure 14. Breakdown of Global AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue
Figure 15. Contribution to Global 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%)
Figure 16. Global AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn
Figure 17. Global AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn
Figure 18. Global AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn
Figure 19. Global AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn
Figure 20. Global AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn
Figure 21. Breakdown of Global AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue
Figure 22. Contribution to Global 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%)
Figure 23. Global AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn
Figure 24. Global AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn
Figure 25. Breakdown of Global AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue
Figure 26. Contribution to Global 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%)
Figure 27. Global AI in Drug Discovery Market: Oncology, 2015-2026, $ mn
Figure 28. Global AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn
Figure 29. Global AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn
Figure 30. Global AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn
Figure 31. Global AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn
Figure 32. Breakdown of Global AI in Drug Discovery Market by Application, 2019-2026, % of Revenue
Figure 33. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 34. Global AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn
Figure 35. Global AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn
Figure 36. Global AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn
Figure 37. Global AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn
Figure 38. Global AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn
Figure 39. Breakdown of Global AI in Drug Discovery Market by End User, 2019-2026, % of Revenue
Figure 40. Contribution to Global 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 41. Global AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn
Figure 42. Global AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn
Figure 43. Global AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn
Figure 44. Global Market Snapshot by Region
Figure 45. Geographic Spread of Worldwide AI in Drug Discovery Market, 2019-2026, % of Revenue
Figure 46. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%)
Figure 47. North American AI in Drug Discovery Market, 2015-2026, $ mn
Figure 48. Breakdown of North America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 50. U.S. AI in Drug Discovery Market, 2015-2026, $ mn
Figure 51. Canada AI in Drug Discovery Market, 2015-2026, $ mn
Figure 52. AI in Drug Discovery Market in Mexico, 2015-2026, $ mn
Figure 53. European AI in Drug Discovery Market, 2015-2026, $ mn
Figure 54. Breakdown of European AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 55. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 56. AI in Drug Discovery Market in UK, 2015-2026, $ mn
Figure 57. AI in Drug Discovery Market in France, 2015-2026, $ mn
Figure 58. AI in Drug Discovery Market in Germany, 2015-2026, $ mn
Figure 59. AI in Drug Discovery Market in Spain, 2015-2026, $ mn
Figure 60. AI in Drug Discovery Market in Italy, 2015-2026, $ mn
Figure 61. AI in Drug Discovery Market in Russia, 2015-2026, $ mn
Figure 62. AI in Drug Discovery Market in Rest of Europe, 2015-2026, $ mn
Figure 63. Asia-Pacific AI in Drug Discovery Market, 2015-2026, $ mn
Figure 64. Breakdown of APAC AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 65. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 66. AI in Drug Discovery Market in China, 2015-2026, $ mn
Figure 67. AI in Drug Discovery Market in Japan, 2015-2026, $ mn
Figure 68. AI in Drug Discovery Market in India, 2015-2026, $ mn
Figure 69. AI in Drug Discovery Market in Australia, 2015-2026, $ mn
Figure 70. AI in Drug Discovery Market in South Korea, 2015-2026, $ mn
Figure 71. AI in Drug Discovery Market in Rest of APAC, 2015-2026, $ mn
Figure 72. South America AI in Drug Discovery Market, 2015-2026, $ mn
Figure 73. Breakdown of South America AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 74. Contribution to South America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 75. AI in Drug Discovery Market in Argentina, 2015-2026, $ mn
Figure 76. AI in Drug Discovery Market in Brazil, 2015-2026, $ mn
Figure 77. AI in Drug Discovery Market in Chile, 2015-2026, $ mn
Figure 78. AI in Drug Discovery Market in Rest of South America, 2015-2026, $ mn
Figure 79. AI in Drug Discovery Market in Rest of the World (RoW), 2015-2026, $ mn
Figure 80. Breakdown of RoW AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 81. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 82. AI in Drug Discovery Market in UAE, 2015-2026, $ mn
Figure 83. AI in Drug Discovery Market in Saudi Arabia, 2015-2026, $ mn
Figure 84. AI in Drug Discovery Market in Egypt, 2015-2026, $ mn
Figure 85. Growth Stage of Global AI in Drug Discovery Industry over the Forecast Period
Figure 86. Share of Developments of Key Vendors by Strategy Type, 2015-2019
Note: Product cover images may vary from those shown
3 of 4
  • Atomwise, Inc.
  • BenevolentAI
  • Berg LLC
  • Bioage
  • BIOAGE
  • Cloud Pharmaceuticals, Inc.
  • Cyclica
  • Deep Genomics
  • Envisagenics
  • Exscientia
  • Google
  • IBM Corporation
  • Insilico Medicine
  • Microsoft Corporation
  • Numedii, Inc.
  • Numerate
  • NVIDIA Corporation
  • Owkin, Inc.
  • Twoxar, Incorporated
  • Verge Genomics
  • Xtalpi, Inc.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll